Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
2,936.00    -13.00 (-0.44%)
Bid:
2,934.00
Ask:
2,938.00
Spread: 4.00 (0.136%)
Market Cap: £4.09b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Director Declaration

27 Mar 2025 09:57

RNS Number : 5029C
Croda International PLC
27 March 2025
 

27 March 2025

 

Croda International Plc

 

Croda International Plc announces that Steve Foots, Group Chief Executive, will join the Board of Tate & Lyle PLC, as a Non-Executive Director with effect from 24 July 2025.

 

There are no further matters to be disclosed under UK Listing Rule 6.4.9.

 

 

For enquiries contact:

 

Investors: David Bishop, Croda +44 7823 874428

Media: Charlie Armitstead, FTI Consulting +44 7703 330269

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNEANDXASSSEEA
Date   Source Headline
4th Aug 20258:46 amRNSDirector/PDMR Shareholding
1st Aug 20253:43 pmRNSDirector/PDMR Shareholding
1st Aug 20251:31 pmRNSDirector/PDMR Shareholding
31st Jul 20253:42 pmRNSDirector/PDMR Shareholding
29th Jul 20252:33 pmRNSDirector/PDMR Shareholding
29th Jul 20252:31 pmRNSDirector/PDMR Shareholding
29th Jul 20257:00 amRNSResults for the six months ended 30 June 2025
16th Jul 20252:08 pmRNSDirector/PDMR Shareholding
12th Jun 202510:01 amRNSDirector/PDMR Shareholding
6th Jun 20258:45 amRNSCorporate Broker Appointment
2nd Jun 20258:44 amRNSDirector/PDMR Shareholding
29th May 20258:57 amRNSDirector/PDMR Shareholding
13th May 20253:48 pmRNSDirector/PDMR Shareholding
6th May 20252:26 pmRNSDirector/PDMR Shareholding
24th Apr 202511:40 amRNSResult of AGM
23rd Apr 20257:00 amRNSFirst quarter 2025 sales update
11th Apr 20252:33 pmRNSDirector/PDMR Shareholding
11th Apr 20252:06 pmRNSDirector/PDMR Shareholding
7th Apr 202511:14 amRNSDirector/PDMR Shareholding
4th Apr 20253:49 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:47 pmRNSDirector/PDMR Shareholding
31st Mar 202512:14 pmRNSDirector/PDMR Shareholding
27th Mar 20259:57 amRNSDirector Declaration
25th Mar 202512:30 pmRNSDirector/PDMR Shareholding
25th Mar 202512:27 pmRNSDirector/PDMR Shareholding
25th Mar 202512:26 pmRNSDirector/PDMR Shareholding
25th Mar 202512:23 pmRNSDirector/PDMR Shareholding
25th Mar 202512:21 pmRNSDirector/PDMR Shareholding
25th Mar 202512:21 pmRNSDirector/PDMR Shareholding
25th Mar 202512:17 pmRNSDirector/PDMR Shareholding
25th Mar 202512:14 pmRNSDirector/PDMR Shareholding
13th Mar 202512:38 pmRNSAnnual Financial Report
11th Mar 20252:54 pmRNSDirector/PDMR Shareholding
11th Mar 20257:13 amRNSDirector Declaration
10th Mar 202510:42 amRNSHolding(s) in Company
3rd Mar 20253:49 pmRNSDirectorate Change
25th Feb 202511:30 amRNSDirector/PDMR Shareholding
25th Feb 20257:00 amRNSFinal Results
11th Feb 20253:12 pmRNSDirector/PDMR Shareholding
13th Jan 20252:19 pmRNSDirector/PDMR Shareholding
11th Dec 20243:09 pmRNSDirector/PDMR Shareholding
11th Dec 20241:54 pmRNSDirector/PDMR Shareholding
9th Dec 20242:36 pmRNSHolding(s) in Company
29th Nov 202412:12 pmRNSHolding(s) in Company
20th Nov 20241:42 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSDirectorate Change
12th Nov 20242:47 pmRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNSThird quarter 2024 sales update
1st Nov 20241:44 pmRNSHolding(s) in Company
11th Oct 20242:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.